September 3, 2021

A monthly recap of the latest news about Alzheimer’s & Dementia

Air Pollution and Dementia: Scientists Find Air Quality and Brain Health Go Hand in Hand

Exposure to air pollution is widely known as a risk factor for health conditions such as lung cancer, heart disease and respiratory infections, but scientists have also turned their attention to its potential consequences for brain health. Read more here.

 

Abnormal cholesterol metabolism linked to dementia risk

Lower levels of bile acids, which are made when the body breaks down cholesterol, are linked to a higher risk of dementia among men, according to a recent NIA study.
Read more here.

 

Study links younger age of onset of type 2 diabetes to increased risk of dementia

People who develop type 2 diabetes at a younger age have an increased risk of dementia, according to a new study funded in part by NIA and published in JAMA on April 27.
Read more here.

 

Future Alzheimer’s treatments aim to do more than clear plaques from the brain

Immune cells, toxic protein tangles and brain waves are among the targets of future Alzheimer’s treatments, scientists say.
Read more here.

 

Dementia risk lower for people in stimulating jobs, research suggests

People with mentally stimulating jobs have a lower risk of dementia in later years than those who have non-stimulating work, research has suggested.
Read more here.

 

New genetically modified mouse model mimics multiple aspects of human Alzheimer’s disease

NIA-supported scientists have developed a new mouse model that produces a form of the human beta-amyloid protein, a hallmark of Alzheimer’s disease.
Read more here.

 

Renewed interest for Galantamine, an 18-year-old Alzheimer’s drug, in the wake of Aduhelm

A recent analysis reveals that people with Alzheimer’s taking Alzheimer’s drug galantamine (Razadyne), approved nearly two decades ago, show moderate cognitive benefits as well as a reduction in mortality and severe dementia. Read more here.

 

Lifestyle slows brain atrophy among indigenous Amazonian people

The Tsimane, an indigenous people of the Bolivian Amazon, have significantly less brain atrophy than their aging peers in the United States and Europe, according to an international study supported in part by NIA. Read more here.